RENOVORX, INC. Diluted Shares Outstanding (Weighted Average)
RENOVORX, INC. (RNXT) reported Diluted Shares Outstanding (Weighted Average) of 47.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- RENOVORX, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 47.30M shares, a 29.31% increase year-over-year.
- RENOVORX, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 38.03M shares, a 21.14% increase year-over-year.
- RENOVORX, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 36.66M shares, a 46.00% increase year-over-year.
- RENOVORX, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 36.65M shares, a 46.93% increase year-over-year.
- RENOVORX, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 35.33M shares, a 58.65% increase from fiscal 2024.
- RENOVORX, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 22.27M shares, a 116.42% increase from fiscal 2023.
- RENOVORX, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 10.29M shares, a 13.69% increase from fiscal 2022.
- RENOVORX, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 9.05M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 47.30M shares 10-Q · filed 2026-08-13 | 42.69M shares 10-Q · filed 2026-08-13 | 40.66M shares derived: average of 3 quarters · filed 2026-08-13 | 39.66M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 38.03M shares 10-Q · filed 2026-05-14 | 37.34M shares derived: average of 2 quarters · filed 2026-05-14 | 37.11M shares derived: average of 3 quarters · filed 2026-05-14 | 36.98M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 36.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 36.65M shares derived: average of 2 quarters · filed 2026-03-30 | 36.63M shares derived: average of 3 quarters · filed 2026-08-13 | 35.33M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 36.65M shares 10-Q · filed 2025-11-13 | 36.61M shares derived: average of 2 quarters · filed 2026-08-13 | 34.89M shares 10-Q · filed 2025-11-13 | 32.43M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 36.58M shares 10-Q · filed 2026-08-13 | 34.00M shares 10-Q · filed 2026-08-13 | 31.03M shares derived: average of 3 quarters · filed 2026-08-13 | 29.51M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 31.40M shares 10-Q · filed 2026-05-14 | 28.25M shares derived: average of 2 quarters · filed 2026-05-14 | 27.15M shares derived: average of 3 quarters · filed 2026-05-14 | 26.37M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 25.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 25.02M shares derived: average of 2 quarters · filed 2026-03-30 | 24.70M shares derived: average of 3 quarters · filed 2026-03-30 | 22.27M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 24.94M shares 10-Q · filed 2025-11-13 | 24.49M shares derived: average of 2 quarters · filed 2025-11-13 | 21.33M shares 10-Q · filed 2025-11-13 | 18.66M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 24.05M shares 10-Q · filed 2025-08-14 | 19.50M shares 10-Q · filed 2025-08-14 | 16.56M shares derived: average of 3 quarters · filed 2025-08-14 | 15.10M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 14.95M shares 10-Q · filed 2025-05-15 | 12.82M shares derived: average of 2 quarters · filed 2025-05-15 | 12.11M shares derived: average of 3 quarters · filed 2025-05-15 | 11.75M shares derived: average of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | 10.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 10.70M shares derived: average of 2 quarters · filed 2025-04-01 | 10.68M shares derived: average of 3 quarters · filed 2025-04-01 | 10.29M shares 10-K · filed 2025-04-01 |
| 2023-09-30 | 10.69M shares 10-Q · filed 2024-11-13 | 10.67M shares derived: average of 2 quarters · filed 2024-11-13 | 10.15M shares 10-Q · filed 2024-11-13 | 9.88M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 10.66M shares 10-Q · filed 2024-08-13 | 9.88M shares 10-Q · filed 2024-08-13 | 9.61M shares derived: average of 3 quarters · filed 2024-08-13 | 9.48M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 9.09M shares 10-Q · filed 2024-05-10 | 9.09M shares derived: average of 2 quarters · filed 2024-05-10 | 9.08M shares derived: average of 3 quarters · filed 2024-05-10 | 9.08M shares derived: average of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | 9.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 9.08M shares derived: average of 2 quarters · filed 2024-04-01 | 9.07M shares derived: average of 3 quarters · filed 2024-04-01 | 9.05M shares 10-K · filed 2024-04-01 |
| 2022-09-30 | 9.07M shares 10-Q · filed 2023-11-13 | 9.06M shares derived: average of 2 quarters · filed 2023-11-13 | 9.04M shares 10-Q · filed 2023-11-13 | |
| 2022-06-30 | 9.06M shares 10-Q · filed 2023-08-16 | 9.02M shares 10-Q · filed 2023-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |